AI
AI

Tag: Lymphoblastic

BLINCYTO® (Blinatunomab) Enhances Survival Rates in Newly Diagnosed Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL) When Combined with Chemotherapy

Photo credit: www.investing.com Amgen's BLINCYTO Shows Significant Survival Benefit in Pediatric B-ALL Patients THOUSAND OAKS, Calif., Dec. 7, 2024 /PRNewswire/ --...